OTC Pharmaceuticals - Mauritius

  • Mauritius
  • Revenue in the OTC Pharmaceuticals market amounts to US$60.18m in 2024. The market is expected to grow annually by 6.13% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$15.49m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$46.22 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.6% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Mauritius is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trend.

Customer preferences play a crucial role in the growth of the OTC Pharmaceuticals market in Mauritius. Consumers are increasingly seeking convenience and accessibility when it comes to healthcare products. This has led to a rise in demand for over-the-counter medications, as they can be easily purchased without a prescription.

Additionally, consumers are becoming more health-conscious and proactive in managing their own health, leading to an increased demand for self-care products. Trends in the market further contribute to the growth of the OTC Pharmaceuticals market in Mauritius. One notable trend is the increasing availability of OTC medications in pharmacies and retail outlets.

This expansion of distribution channels makes it easier for consumers to access these products. Furthermore, there is a growing trend towards natural and herbal remedies, as consumers are becoming more interested in alternative healthcare options. This has led to an increase in the availability and demand for OTC herbal and natural products.

Local special circumstances also impact the development of the OTC Pharmaceuticals market in Mauritius. The country has a well-developed healthcare system, with a strong emphasis on primary healthcare. This focus on prevention and early intervention encourages consumers to take a proactive approach to their health, leading to increased demand for OTC medications.

Additionally, the government has implemented policies to promote the use of generic medications, which are often available over-the-counter. This has further contributed to the growth of the OTC Pharmaceuticals market in Mauritius. Underlying macroeconomic factors also play a role in the development of the OTC Pharmaceuticals market in Mauritius.

The country has experienced steady economic growth in recent years, leading to an increase in disposable income. This has allowed consumers to allocate more of their budget towards healthcare products, including OTC medications. Additionally, the aging population in Mauritius has led to an increase in healthcare needs, further driving the demand for OTC pharmaceuticals.

In conclusion, the OTC Pharmaceuticals market in Mauritius is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trend. As consumers seek convenience and accessibility, the demand for over-the-counter medications continues to rise.

The availability of OTC medications in pharmacies and retail outlets, as well as the growing trend towards natural and herbal remedies, further contribute to the growth of the market. The country's focus on primary healthcare and promotion of generic medications, along with steady economic growth and an aging population, also play a role in the development of the OTC Pharmaceuticals market in Mauritius.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)